MDK6574
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555186

CAS#: 2102196-57-4

Description: MDK6574, also known as FAA1 agonist-1, is a FAA1 agonist. MDK6574 has CAS#2102196-57-4. The last 4 digit of its CAS# is used for naming for the convenience of scientific communication.


Price and Availability

Size
Price

200mg
USD 950
2g
USD 4250
Size
Price

500mg
USD 1950
5g
USD 6950
Size
Price

1g
USD 2650

MDK6574, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 555186
Name: MDK6574
CAS#: 2102196-57-4
Chemical Formula: C21H17ClO5S
Exact Mass: 416.0485
Molecular Weight: 416.872
Elemental Analysis: C, 60.51; H, 4.11; Cl, 8.50; O, 19.19; S, 7.69


Synonym: FAA1 agonist-1; FAA1 agonist 1; FAA1 agonist1; MDK6574; MDK-6574; MDK 6574.

IUPAC/Chemical Name: 2-((4-((2'-chloro-[1,1'-biphenyl]-3-yl)methoxy)phenyl)sulfonyl)acetic acid

InChi Key: YEFZZALZTNOYEA-UHFFFAOYSA-N

InChi Code: InChI=1S/C21H17ClO5S/c22-20-7-2-1-6-19(20)16-5-3-4-15(12-16)13-27-17-8-10-18(11-9-17)28(25,26)14-21(23)24/h1-12H,13-14H2,(H,23,24)

SMILES Code: ClC1=CC=CC=C1C2=CC(COC3=CC=C(S(CC(O)=O)(=O)=O)C=C3)=CC=C2


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1. Li Z, et al. Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. Eur J Med Chem. 2017 Sep 29;138:458-479.